Cutler Group LP Vbi Vaccines Inc Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Jan 18, 2022	SELL	$2.21 - $3.22 $442 - $644	-200 Reduced 33.33%	400 $1,000
Q3 2021 Oct 26, 2021	SELL	$2.8 - $3.72 $15,119 - $20,088	-5,400 Reduced 90.0%	600 $1,000
Q2 2021 Jul 19, 2021	BUY	$2.61 - $4.17 $10,962 - $17,514	4,200 Added 233.33%	6,000 $3,000
Q1 2021 Apr 26, 2021	SELL	$2.91 - $4.32 $15,714 - $23,328	-5,400 Reduced 75.0%	1,800 $2,000
Q4 2020 Jan 21, 2021	BUY	$2.15 - $3.5 $7,740 - $12,600	3,600 Added 100.0%	7,200 $2,000
Q3 2020 Oct 27, 2020	SELL	$2.77 - $6.17 $7,479 - $16,659	-2,700 Reduced 42.86%	3,600 $1,000
Q2 2020 Jul 22, 2020	BUY	$0.87 - $3.13 $5,481 - $19,719	6,300 New	6,300 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.